Last Funding Type: Series B
Total Funding: 185000000.0
Last Funding Date: 2021-09-09
Funding Status: Early Stage Venture
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Investors Number: 16.0
Founded Date: 2018-01-01
Headquarters: New York, New York, United States
Industry: Early Drug Development